FNY Investment Advisers LLC Invests $36,000 in Avantor, Inc. $AVTR

FNY Investment Advisers LLC purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,675 shares of the company’s stock, valued at approximately $36,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Whittier Trust Co. of Nevada Inc. raised its position in shares of Avantor by 3.2% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 118,065 shares of the company’s stock worth $1,589,000 after purchasing an additional 3,704 shares during the period. Whittier Trust Co. increased its position in Avantor by 1.6% in the 2nd quarter. Whittier Trust Co. now owns 224,893 shares of the company’s stock valued at $3,027,000 after acquiring an additional 3,508 shares during the period. DekaBank Deutsche Girozentrale increased its position in Avantor by 56.7% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 628,082 shares of the company’s stock valued at $8,332,000 after acquiring an additional 227,346 shares during the period. Beverly Hills Private Wealth LLC acquired a new stake in Avantor in the 2nd quarter valued at approximately $196,000. Finally, Chicago Partners Investment Group LLC acquired a new stake in Avantor in the 2nd quarter valued at approximately $217,000. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on AVTR. Morgan Stanley lowered their target price on Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Monday, August 4th. Stifel Nicolaus set a $12.00 target price on Avantor and gave the company a “hold” rating in a research report on Monday, August 4th. Robert W. Baird raised their target price on Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday. JPMorgan Chase & Co. lowered their target price on Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Avantor in a research note on Friday, August 1st. Seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $15.96.

Avantor Stock Performance

Shares of NYSE AVTR opened at $15.44 on Friday. The stock has a fifty day moving average price of $13.33 and a two-hundred day moving average price of $13.36. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. The firm has a market cap of $10.52 billion, a P/E ratio of 15.59, a PEG ratio of 5.05 and a beta of 0.98. Avantor, Inc. has a 1 year low of $10.82 and a 1 year high of $23.70.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Avantor had a net margin of 10.31% and a return on equity of 11.39%. The business’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.25 earnings per share. Research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,476 shares of the firm’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at $627,224.52. This trade represents a 5.94% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.20% of the stock is currently owned by corporate insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.